Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA FMD VACCINE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 ECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 EPIDEMIOLOGY OF FOOT-AND-MOUTH DISEASE (FMD)
4.3.1 FMD INCIDENCE RATE BY SPECIES AND REGION
4.3.1.1 INCIDENCE BY SPECIES AND MORBIDITY BURDEN
4.3.1.2 PREVALENCE PATTERNS AND REGIONAL SEROTYPE DISTRIBUTION
4.3.2 VACCINATION COVERAGE RATE
4.4 MORTALITY AND MORBIDITY IMPACT
4.4.1 VACCINE COMPLIANCE AND PROGRAM ADHERENCE
4.4.2 DISEASE CONTAINMENT SUCCESS RATES
4.5 INDUSTRY INSIGHTS
4.5.1 MICRO AND MACRO ECONOMIC FACTORS
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.5.3 KEY PRICING STRATEGIES
4.5.4 INTERVIEWS WITH SPECIALISTS
4.5.5 ANALYSIS AND RECOMMENDATION
4.6 COMPANY EVALUATION QUADRANT
4.7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
4.8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
4.9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
4.1 MIDDLE EAST AND AFRICA CLINICAL TRIAL MARKET FOR MIDDLE EAST AND AFRICA FMD VACCINE MARKET
4.11 HEALTHCARE TARIFFS IMPACT ANALYSIS
4.11.1 OVERVIEW
4.11.2 TARIFF STRUCTURES
4.11.2.1 MIDDLE EAST AND AFRICA VS. REGIONAL TARIFF STRUCTURES
4.11.2.2 UNITED STATES: USDA/APHIS TARIFF POLICIES, ANIMAL HEALTH PROGRAM MODELS
4.11.2.2.1 EUROPEAN UNION: CROSS-BORDER TRADE REGULATIONS, SUBSIDY POLICIES
4.11.2.2.2 ASIA-PACIFIC: IMPORT AND EXPORT CONTROLS ON VETERINARY VACCINES
4.11.2.2.3 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
4.11.3 PHARMACEUTICAL (VETERINARY BIOLOGICS) TARIFFS AND TRADE BARRIERS
4.11.3.1 IMPORT DUTIES ON VACCINES AND BIOLOGICALS
4.11.3.2 IMPACT ON AFFORDABILITY AND ACCESS IN RURAL AREAS
4.11.3.3 KEY TRADE AGREEMENTS AFFECTING ANIMAL HEALTH PRODUCT TARIFFS
4.11.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND FARMERS
4.11.4.1 COST BURDEN ON COMMERCIAL FARMS AND VETERINARIANS
4.11.4.2 EFFECT ON VACCINE AFFORDABILITY AND HERD COVERAGE
4.11.4.3 TARIFFS AND IMPACT ON ANIMAL TRADE/MOVEMENT
4.11.5 TRADE AGREEMENTS AND ANIMAL HEALTH TARIFFS
4.11.5.1 WTO REGULATIONS ON VETERINARY PRODUCTS
4.11.5.2 IMPACT OF TRADE WARS ON VACCINE SUPPLY CHAIN
4.11.5.3 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN TARIFF REDUCTION
4.11.6 IMPACT OF TARIFFS ON VETERINARY VACCINE COSTS & ACCESSIBILITY
4.11.7 IMPORTANCE OF TARIFFS IN THE ANIMAL HEALTH SECTOR
4.12 MARKETED VACCINE ANALYSIS
4.12.1 VACCINE BRAND & GENERIC NAME / ANTIGENIC STRAIN
4.12.2 INDICATION
4.12.3 PHARMACOLOGICAL CLASS OF THE VACCINE
4.12.4 PRIMARY INDICATION
4.12.5 MARKET STATUS
4.12.6 VACCINE TYPE (CONVENTIONAL, NEXT-GEN, ETC.)
4.12.7 DOSAGE FORM
4.12.8 DOSAGE AVAILABILITY
4.12.9 PACKAGING TYPE
4.12.10 ROUTE OF ADMINISTRATION
4.12.11 DOSING FREQUENCY
4.12.12 VACCINE INSIGHT
4.12.13 OVERVIEW OF DEVELOPMENT ACTIVITIES (APPROVALS, SAFETY, EFFICACY, MARKET EXCLUSIVITY)
4.12.13.1 FORECAST MARKET OUTLOOK
4.12.14 CROSS COMPETITION (BY STRAIN/VALENCY)
4.12.15 THERAPEUTIC PORTFOLIO
4.12.16 CURRENT DEVELOPMENT SCENARIO
4.13 PATENT ANALYSIS
4.13.1 PATENT QUALITY AND STRENGTH
4.13.2 COUNTRY PATENT LANDSCAPE
4.13.3 IP STRATEGY AND MANAGEMENT
4.13.4 LICENSING AND COLLABORATION
4.14 TOP ENTITIES BASED ON R&D GLANCE FOR MIDDLE EAST AND AFRICA FMD VACCINE MARKET
4.15 MARKET ACCESS
4.15.1 10-YEAR MARKET FORECAST
4.15.2 CLINICAL TRIAL RECENT UPDATES
4.15.3 ANNUAL NEW VACCINE APPROVALS (OIE/REGIONAL AUTHORITIES)
4.15.4 LEADING MANUFACTURERS AND STRATEGIC DEALS
4.15.5 MAJOR VACCINE UPTAKE
4.15.6 CURRENT VACCINATION PRACTICES
4.15.7 IMPACT OF UPCOMING TECHNOLOGIES AND THERAPY
4.16 R & D ANALYSIS
4.16.1 COMPARATIVE ANALYSIS
4.16.2 VACCINE DEVELOPMENT LANDSCAPE
4.16.3 IN-DEPTH INSIGHTS ON REGULATORY MILESTONES
4.16.4 THERAPEUTIC ASSESSMENT
4.16.5 ASSET-BASED COLLABORATIONS AND PARTNERSHIPS
5 WAR-DRIVEN DISRUPTION IN VETERINARY VACCINE SUPPLY CHAINS, GEOGRAPHIC FOOTPRINTS, STRUCTURAL CHANGES, AND ADAPTIVE STRATEGIES
5.1 SUPPLY CHAIN RESILIENCE
5.1.1 DIVERSIFICATION OF ANTIGEN AND ADJUVANT INGREDIENT SUPPLIERS
5.1.2 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE MANUFACTURING HUBS
5.1.3 STRATEGIC STOCKPILING OF EMERGENCY VACCINE BANKS
5.1.4 DEVELOPMENT OF ALTERNATIVE COLD CHAIN LOGISTICS ROUTES
5.1.5 STRATEGIC PARTNERSHIPS WITH CONTRACT MANUFACTURERS (CDMOS)
5.1.6 EXPANSION OF VACCINE FILL-FINISH AND PACKAGING CAPACITIES
5.2 ENERGY & MANUFACTURING OPERATIONAL COST RISK
5.2.1 RISING ENERGY COSTS IN ANIMAL HEALTH PRODUCTION FACILITIES
5.2.2 INCREASED COSTS FOR BIOLOGICS RAW MATERIALS AND COMPONENTS
5.2.3 LONG-TERM ENERGY PROCUREMENT STRATEGIES FOR VETERINARY PLANTS
5.2.4 ADOPTION OF ENERGY-EFFICIENT BIOPHARMA MANUFACTURING TECHNOLOGIES
5.2.5 DEPLOYMENT OF ADVANCED AUTOMATION AND CONTINUOUS MANUFACTURING
5.2.6 INTEGRATION OF RENEWABLE ENERGY IN VETERINARY VACCINE PLANTS
5.3 GEOGRAPHIC FOOTPRINT REASSESSMENT
5.3.1 EXPANSION OF VACCINE PRODUCTION IN POLITICALLY STABLE REGIONS
5.3.2 DIVERSIFICATION OF MIDDLE EAST AND AFRICA VETERINARY VACCINE BASES
5.3.3 RELOCATION OF ANTIGEN PRODUCTION FACILITIES
5.3.4 EXPANSION OF MANUFACTURING IN EMERGING ANIMAL HEALTH MARKETS
5.3.5 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE DISTRIBUTION HUBS
5.4 SCENARIO PLANNING & RISK MANAGEMENT
5.4.1 DEVELOPMENT OF SUPPLY CHAIN CONTINGENCY PLANS FOR OUTBREAKS
5.4.2 MULTI-SOURCE PROCUREMENT STRATEGIES FOR KEY VACCINE INGREDIENTS
5.4.3 GOVERNMENT AND ANIMAL HEALTH AUTHORITY COLLABORATIONS
5.4.4 CRISIS-RESPONSE VACCINE DEPLOYMENT NETWORKS
5.4.5 DEPLOYMENT OF SUPPLY CHAIN ANALYTICS IN VACCINE DISTRIBUTION
5.5 CASH & FINANCIAL PROTECTION
5.5.1 STRENGTHENING CAPITAL RESERVES FOR MANUFACTURING EXPANSION
5.5.2 DIVERSIFICATION OF PRODUCT PORTFOLIOS AND REVENUE STREAMS
5.5.3 INVESTMENTS IN DOMESTIC VACCINE MANUFACTURING INFRASTRUCTURE
5.5.4 GOVERNMENT INCENTIVES FOR ANIMAL HEALTH PRODUCTION
5.5.5 LONG-TERM PROCUREMENT AGREEMENTS WITH GOVERNMENTS AND ORGANIZATIONS
5.6 DATA PROTECTION
5.6.1 DATA PROTECTION FRAMEWORKS FOR ANIMAL HEALTH R&D AND MANUFACTURING
5.6.2 PROTECTION OF VETERINARY CLINICAL TRIAL AND FIELD DATA
5.6.3 SECURE CLOUD INFRASTRUCTURE FOR VACCINE DATA MANAGEMENT
5.6.4 AI-DRIVEN THREAT DETECTION IN RESEARCH AND SUPPLY NETWORKS
5.6.5 COMPLIANCE WITH MIDDLE EAST AND AFRICA ANIMAL HEALTH DATA REGULATIONS AND GXP STANDARDS
6 REGULATORY FRAMEWORK FOR FMD VACCINES
6.1 REGULATORY APPROVAL PROCESS FOR FMD VACCINES
6.1.1 INTERNATIONAL NORMS AND STANDARDS FOR FMD VACCINES
6.1.2 BIOSAFETY AND CONTAINMENT REGULATIONS
6.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.3 REGULATORY APPROVAL PATHWAYS FOR VETERINARY VACCINES
6.4 LICENSING AND REGISTRATION REQUIREMENTS
6.5 POST-MARKETING SURVEILLANCE FOR VETERINARY PRODUCTS
6.6 GOOD MANUFACTURING PRACTICES (GMP) GUIDELINES FOR ANIMAL HEALTH
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWTH IN MIDDLE EAST AND AFRICA LIVESTOCK POPULATION
7.1.2 RISING PREVALENCE OF FMD OUTBREAKS
7.1.3 GROWING GOVERNMENT VACCINATION PROGRAMS
7.1.4 INCREASING AWARENESS OF ANIMAL HEALTH AND BIOSECURITY
7.2 RESTRAINTS
7.2.1 LIMITED COLD CHAIN INFRASTRUCTURE
7.2.2 VACCINE HESITANCY AND FIELD CHALLENGES
7.3 OPPORTUNITIES
7.3.1 INTEGRATION OF DIGITAL VETERINARY SURVEILLANCE SYSTEMS
7.3.2 RISING ADOPTION OF MULTIVALENT AND HIGH-POTENCY VACCINES
7.3.3 EMERGING MARKETS WITH HIGH LIVESTOCK POPULATIONS
7.4 CHALLENGES
7.4.1 VIRAL MUTATION AND SEROTYPE VARIABILITY
7.4.2 ENFORCEMENT OF VACCINATION REGULATIONS
8 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CONVENTIONAL VACCINES
8.3 NEXT-GENERATION / ADVANCED VACCINES
8.4 OTHERS
8.5 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
8.5.1 CONVENTIONAL VACCINES
8.5.2 NEXT-GENERATION / ADVANCED VACCINES
8.5.3 OTHERS
9 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE
9.1 OVERVIEW
9.2 INACTIVATED (KILLED) VACCINES
9.3 LIVE ATTENUATED VACCINES
9.4 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 ASIA-PACIFIC
9.4.2 EUROPE
9.4.3 NORTH AMERICA
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST AND AFRICA
9.5 MIDDLE EAST AND AFRICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.5.1 RECOMBINANT VECTOR-BASED VACCINES
9.5.2 VIRUS-LIKE PARTICLE (VLP) VACCINES
9.5.3 SUBUNIT VACCINES
9.5.4 OTHERS
9.6 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 ASIA-PACIFIC
9.6.2 EUROPE
9.6.3 NORTH AMERICA
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST AND AFRICA
9.7 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 ASIA-PACIFIC
9.7.2 EUROPE
9.7.3 NORTH AMERICA
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST AND AFRICA
9.8 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.8.1 MULTIVALENT VACCINES
9.8.2 MONOVALENT VACCINES
9.9 MIDDLE EAST AND AFRICA MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.9.1 ASIA-PACIFIC
9.9.2 EUROPE
9.9.3 NORTH AMERICA
9.9.4 SOUTH AMERICA
9.9.5 MIDDLE EAST AND AFRICA
9.1 MIDDLE EAST AND AFRICA MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 ASIA-PACIFIC
9.10.2 EUROPE
9.10.3 NORTH AMERICA
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
10 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE
10.1 OVERVIEW
10.2 INTRAMUSCULAR
10.3 SUBCUTANEOUS
10.4 OTHERS
10.5 MIDDLE EAST AND AFRICA INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.5.1 ASIA-PACIFIC
10.5.2 EUROPE
10.5.3 NORTH AMERICA
10.5.4 SOUTH AMERICA
10.5.5 MIDDLE EAST AND AFRICA
10.6 MIDDLE EAST AND AFRICA SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.6.1 ASIA-PACIFIC
10.6.2 EUROPE
10.6.3 NORTH AMERICA
10.6.4 SOUTH AMERICA
10.6.5 MIDDLE EAST AND AFRICA
10.7 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 ASIA-PACIFIC
10.7.2 EUROPE
10.7.3 NORTH AMERICA
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
11 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE
11.1 OVERVIEW
11.2 BOVINE
11.3 PORCINE
11.4 OVINE
11.5 CAPRINE
11.6 OTHERS
11.7 MIDDLE EAST AND AFRICA BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.7.1 ASIA-PACIFIC
11.7.2 EUROPE
11.7.3 NORTH AMERICA
11.7.4 SOUTH AMERICA
11.7.5 MIDDLE EAST AND AFRICA
11.8 MIDDLE EAST AND AFRICA PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.8.1 ASIA-PACIFIC
11.8.2 EUROPE
11.8.3 NORTH AMERICA
11.8.4 SOUTH AMERICA
11.8.5 MIDDLE EAST AND AFRICA
11.9 MIDDLE EAST AND AFRICA OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.9.1 ASIA-PACIFIC
11.9.2 EUROPE
11.9.3 NORTH AMERICA
11.9.4 SOUTH AMERICA
11.9.5 MIDDLE EAST AND AFRICA
11.1 MIDDLE EAST AND AFRICA CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.10.1 ASIA-PACIFIC
11.10.2 EUROPE
11.10.3 NORTH AMERICA
11.10.4 SOUTH AMERICA
11.10.5 MIDDLE EAST AND AFRICA
11.11 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.11.1 ASIA-PACIFIC
11.11.2 EUROPE
11.11.3 NORTH AMERICA
11.11.4 SOUTH AMERICA
11.11.5 MIDDLE EAST AND AFRICA
12 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE
12.1 OVERVIEW
12.2 LIQUID VACCINES
12.3 LYOPHILIZED (FREEZE-DRIED) VACCINES
12.4 OTHERS
12.5 MIDDLE EAST AND AFRICA LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 ASIA-PACIFIC
12.5.2 EUROPE
12.5.3 NORTH AMERICA
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST AND AFRICA
12.6 MIDDLE EAST AND AFRICA LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 ASIA-PACIFIC
12.6.2 EUROPE
12.6.3 NORTH AMERICA
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 ASIA-PACIFIC
12.7.2 EUROPE
12.7.3 NORTH AMERICA
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
13 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ROUTINE PROPHYLACTIC VACCINATION
13.3 EMERGENCY VACCINATION (OUTBREAK CONTROL)
13.4 OTHERS
13.5 MIDDLE EAST AND AFRICA ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 ASIA-PACIFIC
13.5.2 EUROPE
13.5.3 NORTH AMERICA
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 MIDDLE EAST AND AFRICA EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 ASIA-PACIFIC
13.6.2 EUROPE
13.6.3 NORTH AMERICA
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 ASIA-PACIFIC
13.7.2 EUROPE
13.7.3 NORTH AMERICA
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER
14.1 OVERVIEW
14.2 COMMERCIAL LIVESTOCK FARMS
14.3 VETERINARY HOSPITALS
14.4 VETERINARY CARE CENTERS
14.5 VACCINATION CENTRES
14.6 OTHERS
14.7 MIDDLE EAST AND AFRICA COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 ASIA-PACIFIC
14.7.2 EUROPE
14.7.3 NORTH AMERICA
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST AND AFRICA
14.8 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 ASIA-PACIFIC
14.8.2 EUROPE
14.8.3 NORTH AMERICA
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST AND AFRICA
14.9 MIDDLE EAST AND AFRICA VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.9.1 ASIA-PACIFIC
14.9.2 EUROPE
14.9.3 NORTH AMERICA
14.9.4 SOUTH AMERICA
14.9.5 MIDDLE EAST AND AFRICA
14.1 MIDDLE EAST AND AFRICA VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.10.1 ASIA-PACIFIC
14.10.2 EUROPE
14.10.3 NORTH AMERICA
14.10.4 SOUTH AMERICA
14.10.5 MIDDLE EAST AND AFRICA
14.11 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.11.1 ASIA-PACIFIC
14.11.2 EUROPE
14.11.3 NORTH AMERICA
14.11.4 SOUTH AMERICA
14.11.5 MIDDLE EAST AND AFRICA
15 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY)
15.3 RETAIL SALES
15.4 OTHERS
15.5 MIDDLE EAST AND AFRICA DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.5.1 ASIA-PACIFIC
15.5.2 EUROPE
15.5.3 NORTH AMERICA
15.5.4 SOUTH AMERICA
15.5.5 MIDDLE EAST AND AFRICA
15.6 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
15.6.1 HOSPITAL PHARMACY
15.6.2 RETAIL PHARMACY
15.6.3 ONLINE PHARMACY
15.7 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.7.1 ASIA-PACIFIC
15.7.2 EUROPE
15.7.3 NORTH AMERICA
15.7.4 SOUTH AMERICA
15.7.5 MIDDLE EAST AND AFRICA
15.8 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.8.1 ASIA-PACIFIC
15.8.2 EUROPE
15.8.3 NORTH AMERICA
15.8.4 SOUTH AMERICA
15.8.5 MIDDLE EAST AND AFRICA
16 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY REGION
16.1 MIDDLE EAST AND AFRICA
16.1.1 SOUTH AFRICA
16.1.2 EGYPT
16.1.3 SAUDI ARABIA
16.1.4 ISRAEL
16.1.5 UAE
16.1.6 KUWAIT
16.1.7 OMAN
16.1.8 QATAR
16.1.9 BAHRAIN
16.1.10 REST OF MEA
17 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
19.1.1 COMPANY SNAPSHOT
19.1.2 COMPANY SHARE ANALYSIS
19.1.3 PRODUCT PORTFOLIO
19.1.4 RECENT DEVELOPMENT
19.2 CEVA SANTÉ ANIMALE
19.2.1 COMPANY SNAPSHOT
19.2.2 COMPANY SHARE ANALYSIS
19.2.3 PRODUCT PORTFOLIO
19.2.4 RECENT DEVELOPMENT
19.3 CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 INDIAN IMMUNOLOGICALS LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 BIOGÉNESIS BAGÓ
19.5.1 COMPANY SNAPSHOT
19.5.2 COMPANY SHARE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENT
19.6 BIOVET PRIVATE LTD
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENT
19.7 BRILLIANT BIO PHARMA
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 DOLLVET
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENT
19.9 ENIMMUNE CORP.
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENT
19.1 JINYU BIOTECHNOLOGY CO., LTD.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 KENYA VETERINARY VACCINES PRODUCTION INSTITUTE
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LIMOR DE COLOMBIA SAS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 MEVAC FOR VACCINES
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 NATIONAL VETERINARY INSTITUTE
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 SHCHELKOVO BIOCOMBINAT
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 VETAL S.A.
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 VECOL
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
19.19 WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENT
19.2 ZOETIS SERVICES LLC
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST AND AFRICA FMD VACCINE PRICING STRUCTURE
TABLE 2 FMD SEROTYPE PREVALENCE BY REGION
TABLE 3 ECONOMIC IMPACT OF FMD OUTBREAKS
TABLE 4 MANUFACTURER POSITIONING MAP
TABLE 5 FMD INCIDENCE, MORBIDITY, AND EPIDEMIOLOGICAL RATES
TABLE 6 FMD SEROTYPE PREVALENCE BY REGION
TABLE 7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
TABLE 8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
TABLE 9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE MIDDLE EAST AND AFRICA FMD VACCINE MARKET
TABLE 10 MIDDLE EAST AND AFRICA CLINICAL TRIAL MARKET FOR MIDDLE EAST AND AFRICA FMD VACCINE MARKET
TABLE 11 DOSAGE FORM CHARACTERISTICS OF FMD VACCINES
TABLE 12 DOSAGE AVAILABILITY OF MARKETED FMD VACCINES
TABLE 13 THERAPEUTIC PORTFOLIO DIVERSIFICATION IN FMD VACCINES
TABLE 14 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2025
TABLE 15 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 16 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 17 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2025
TABLE 18 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 27 MIDDLE EAST AND AFRICA SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 30 MIDDLE EAST AND AFRICA BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 MIDDLE EAST AND AFRICA PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 MIDDLE EAST AND AFRICA CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 36 MIDDLE EAST AND AFRICA LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 MIDDLE EAST AND AFRICA LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION, 2025
TABLE 40 MIDDLE EAST AND AFRICA ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 MIDDLE EAST AND AFRICA EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER, 2025
TABLE 44 MIDDLE EAST AND AFRICA COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
TABLE 50 MIDDLE EAST AND AFRICA DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA
TABLE 57 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 59 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 60 MIDDLE EAST AND AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 61 TABLE
TABLE 62 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 64 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 65 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 67 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 68 TABLE
TABLE 69 MIDDLE EAST AND AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 70 SOUTH AFRICA
TABLE 71 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 72 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 73 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 74 SOUTH AFRICA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 75 SOUTH AFRICA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 SOUTH AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 77 SOUTH AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 78 SOUTH AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 79 SOUTH AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 SOUTH AFRICA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 81 SOUTH AFRICA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 82 SOUTH AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 83 SOUTH AFRICA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 EGYPT
TABLE 85 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 87 EGYPT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 88 EGYPT CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 EGYPT NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 90 EGYPT FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 91 EGYPT FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 92 EGYPT FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 EGYPT FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 EGYPT FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 95 EGYPT FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 96 EGYPT FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 97 EGYPT RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 98 SAUDI ARABIA
TABLE 99 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 101 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 102 SAUDI ARABIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 103 SAUDI ARABIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 SAUDI ARABIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 105 SAUDI ARABIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 106 SAUDI ARABIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 SAUDI ARABIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 SAUDI ARABIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 109 SAUDI ARABIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 110 SAUDI ARABIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 111 SAUDI ARABIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 112 ISRAEL
TABLE 113 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 115 ISRAEL FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 116 ISRAEL CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 ISRAEL NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 118 ISRAEL FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 ISRAEL FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 120 ISRAEL FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 ISRAEL FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 ISRAEL FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 123 ISRAEL FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 124 ISRAEL FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 125 ISRAEL RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 126 UAE
TABLE 127 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 129 UAE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 130 UAE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 131 UAE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 132 UAE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 133 UAE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 134 UAE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 UAE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 UAE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 137 UAE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 138 UAE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 139 UAE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 140 KUWAIT
TABLE 141 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 143 KUWAIT FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 144 KUWAIT CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 KUWAIT NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 KUWAIT FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 147 KUWAIT FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 148 KUWAIT FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 149 KUWAIT FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 150 KUWAIT FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 151 KUWAIT FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 152 KUWAIT FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL 2018-2033 (USD THOUSAND)
TABLE 153 KUWAIT RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 OMAN
TABLE 155 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 157 OMAN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 158 OMAN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 159 OMAN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 160 OMAN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 161 OMAN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 162 OMAN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 OMAN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 OMAN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 165 OMAN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 166 OMAN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 167 OMAN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 168 QATAR
TABLE 169 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 171 QATAR FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 172 QATAR CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 173 QATAR NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 QATAR FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 175 QATAR FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 176 QATAR FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 QATAR FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 178 QATAR FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 179 QATAR FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 180 QATAR FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 181 QATAR RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 182 BAHRAIN
TABLE 183 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 184 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 185 BAHRAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 186 BAHRAIN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 187 BAHRAIN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 188 BAHRAIN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 189 BAHRAIN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 190 BAHRAIN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 BAHRAIN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 192 BAHRAIN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 193 BAHRAIN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 194 BAHRAIN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 195 BAHRAIN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 196 REST OF MEA
TABLE 197 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 199 REST OF MEA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 200 REST OF MEA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 REST OF MEA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 202 REST OF MEA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 203 REST OF MEA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 204 REST OF MEA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 REST OF MEA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 REST OF MEA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 207 REST OF MEA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 208 REST OF MEA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL , 2018-2033 (USD THOUSAND)
TABLE 209 REST OF MEA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: MIDDLE EAST AND AFRICA VS REGIONAL ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA FMD VACCINE MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: SEGMENTATION
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 RISING PREVALENCE OF FOOT-AND-MOUTH DISEASE AND INCREASING GOVERNMENT-LED MASS VACCINATION PROGRAMS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA FMD VACCINE MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 14 CONVENTIONAL VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA FMD VACCINE MARKET IN 2026 & 2033
FIGURE 15 STANDARD DOSING SCHEDULE OF FMD VACCINE
FIGURE 16 TOP ENTITIES BASED ON R&D GLANCE FOR MIDDLE EAST AND AFRICA FMD VACCINE MARKET
FIGURE 17 DROC ANALYSIS
FIGURE 18 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 19 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2025
FIGURE 20 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2032
FIGURE 21 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 22 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2025
FIGURE 23 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE
FIGURE 24 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE, 2018-2032
FIGURE 25 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY TYPE
FIGURE 26 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2025
FIGURE 27 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 28 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2032
FIGURE 29 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 30 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2025
FIGURE 31 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 32 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2032
FIGURE 33 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 34 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2025
FIGURE 35 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 36 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2032
FIGURE 37 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 38 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION, 2025
FIGURE 39 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION
FIGURE 40 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION, 2018-2032
FIGURE 41 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY APPLICATION
FIGURE 42 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER, 2025
FIGURE 43 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER
FIGURE 44 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER, 2018-2032
FIGURE 45 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY END USER
FIGURE 46 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 47 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 48 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 49 MIDDLE EAST AND AFRICA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 50 MIDDLE EAST AND AFRICA FMD VACCINE MARKET SNAPSHOTS
FIGURE 51 MIDDLE EAST AND AFRICA FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
